In chronic lymphocytic leukemia (CLL), the most ... Today, the challenge is to improve management of elderly patients. In this population, outcome of treatment with newer highly effective ...
A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment ... and about 45%-60% of adults have long-term disease-free survival.
Hosted on MSN1mon
European treatment recommendations in the fight against acute lymphoblastic leukemiaThe treatment of acute lymphoblastic leukemia in adults is extremely complex, lengthy, and very stressful for patients. Compared to other types of cancer in adults, ALL is relatively rare ...
Learn about Acute Lymphoblastic Leukemia ALL including its symptoms treatment options and survival rates Expert share insights into life expectancy and the impact of this aggressive cancer on patients ...
In this video, Catherine Lai, MD, MPH discusses the results of a study presented at ASH Annual Meeting that examined time to treatment initiation in patients with acute myeloid leukemia.
The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...
Data are now accumulating on the feasibility of various treatment options ... incidence of chronic lymphocytic leukemia (CLL) is dramatically increased in elderly patients although knowledge ...
The team discovered a unique population of immune cells that is important to the successful treatment of relapsed acute myeloid leukemia (AML). This investigation was done in partnership with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results